5-Fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma
Explore this paper's citation graph
Summary
Neither 5-FU alone, epirubicin alone, or the combination have a major impact in the treatment of gastric carcinoma.
- Type
- article
- Published
- 2004-01-01
- Cited by
- 19
- References
- 8
- OpenAlex
- https://openalex.org/W2077782874
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8207594
Keywords
Epirubicin, Fluorouracil, Gastric carcinoma, Medicine, Carcinoma
References
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
- Cancer statistics, 1992
- A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
- Current status of chemotherapy for advanced pancreatic and gastric cancer.
- Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
- Nonparametric Estimation from Incomplete Observations
- Nonparametric Estimation from Incomplete Observations
Cited by
- Irinotecan, Fluorouracil and Folinic ACID (FOLFIRI) as Effective Treatment Combination for Patients with Advanced Gastric Cancer in Poor Clinical Condition
- Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.
- Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
- Chemotherapy for advanced gastric cancer.
- Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
- Treatment options in patients with metastatic gastric cancer: current status and future perspectives.
- The role of chemotherapy in patients with established gastric cancer.
- Recent advances in chemotherapy for advanced gastric cancer.
- Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
- Systemic therapy for advanced gastric cancer: a clinical practice guideline.
- Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.
- The treatment of advanced gastric cancer: current strategies and future perspectives.
- Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials
- Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
- Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?
- The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.
- Efficacy and Toxicity of Cisplatin and Capecitabine Combination in the First-Line Treatment of Patients with Advanced Gastric Cancer: A Multicenter Study by the Anatolian Society of Medical Oncology
- TOXview: a novel graphical presentation of cancer treatment toxicity profiles
- National Institute for Health and Clinical Excellence
Related papers
- A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group.
- A Skin Manifestation due to the Intraarterial Infusion of Epirubicin.
- Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model.
- FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy.
- Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer.
- High Doses of 5-Fluorouracil and Epirubicin with or without Cisplatin in Advanced Gastric Cancer: A Randomized Study
- Pharmacokinetical Study of 5-fluorouracil Based Sustained Rlease Chemotherapy
- Oxaliplatin Combined with 5-Fluorouracil for Advanced Gastric Carcinoma:a Report of 42 Cases